- Home
- Publications
- Publication Search
- Publication Details
Title
In situvaccination for the treatment of cancer
Authors
Keywords
-
Journal
Immunotherapy
Volume 8, Issue 3, Pages 315-330
Publisher
Future Medicine Ltd
Online
2016-02-10
DOI
10.2217/imt.15.120
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Lymphoma: Immune Evasion Strategies
- (2015) Ranjan Upadhyay et al. Cancers
- Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models
- (2015) Wei Zhang et al. NEOPLASIA
- Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma
- (2014) Arne Kolstad et al. BLOOD
- Tumor-specific oncolytic adenoviruses expressing granulocyte macrophage colony-stimulating factor or anti-CTLA4 antibody for the treatment of cancers
- (2014) T Du et al. CANCER GENE THERAPY
- Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression
- (2014) A. Rodriguez-Garcia et al. CLINICAL CANCER RESEARCH
- Imiquimod in the Treatment of Breast Cancer Skin Metastasis
- (2014) Lisa Henriques et al. JOURNAL OF CLINICAL ONCOLOGY
- TLR Ligands in the Local Treatment of Established Intracerebral Murine Gliomas
- (2014) O. M. Grauer et al. JOURNAL OF IMMUNOLOGY
- Effective Innate and Adaptive Antimelanoma Immunity through Localized TLR7/8 Activation
- (2014) Manisha Singh et al. JOURNAL OF IMMUNOLOGY
- CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
- (2014) Christine E Engeland et al. MOLECULAR THERAPY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Therapeutic In Situ Autovaccination against Solid Cancers with Intratumoral Poly-ICLC: Case Report, Hypothesis, and Clinical Trial
- (2014) A. M. Salazar et al. Cancer Immunology Research
- Converting tumors into vaccine manufacturing factories: DC recruitment, activation and clinical responses with a flt3L-primed in situ vaccine for low-grade lymphoma [nct01976585]
- (2014) Nina Bhardwaj et al. Journal for ImmunoTherapy of Cancer
- Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
- (2013) C. J. Breitbach et al. CANCER RESEARCH
- Controlled Local Delivery of CTLA-4 Blocking Antibody Induces CD8+ T-Cell-Dependent Tumor Eradication and Decreases Risk of Toxic Side Effects
- (2013) M. F. Fransen et al. CLINICAL CANCER RESEARCH
- Oncolytic vaccines
- (2013) Noura B Elsedawy et al. Expert Review of Vaccines
- Fms-like tyrosine kinase 3 receptor ligand (Flt3L)-based vaccination administered with an adenoviral vector prevents tumor growth of colorectal cancer in a BALB/c mouse model
- (2013) Carina Riediger et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- Intratumoral IL-12 combined with CTLA-4 blockade elicits T cell–mediated glioma rejection
- (2013) Johannes vom Berg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Oncolytic viruses as therapeutic cancer vaccines
- (2013) David L Bartlett et al. Molecular Cancer
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
- (2013) Caroline J. Voskens et al. PLoS One
- Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model
- (2013) T. A. Cheema et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma
- (2012) S. J. Dovedi et al. BLOOD
- Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus
- (2012) I. Diaconu et al. CANCER RESEARCH
- Oncolytic Immunotherapy of Advanced Solid Tumors with a CD40L-Expressing Replicating Adenovirus: Assessment of Safety and Immunologic Responses in Patients
- (2012) S. Pesonen et al. CANCER RESEARCH
- Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
- (2012) S. Adams et al. CLINICAL CANCER RESEARCH
- Synergy of Topical Toll-like Receptor 7 Agonist with Radiation and Low-Dose Cyclophosphamide in a Mouse Model of Cutaneous Breast Cancer
- (2012) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- Enhanced antitumoral efficacy and immune response following conditionally replicative adenovirus containing constitutive HSF1 delivery to rodent tumors
- (2012) Rong Fan et al. Journal of Translational Medicine
- An Oncolytic Adenovirus Enhanced for Toll-like Receptor 9 Stimulation Increases Antitumor Immune Responses and Tumor Clearance
- (2012) Vincenzo Cerullo et al. MOLECULAR THERAPY
- The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice
- (2012) Diana M Rommelfanger et al. MOLECULAR THERAPY
- An In Situ Autologous Tumor Vaccination with Combined Radiation Therapy and TLR9 Agonist Therapy
- (2012) Huagang Zhang et al. PLoS One
- In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
- (2011) Y. H. Kim et al. BLOOD
- Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice
- (2011) Sally M. Amos et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- FLT3 Ligand Enhances the Cancer Therapeutic Potency of Naked RNA Vaccines
- (2011) S. Kreiter et al. CANCER RESEARCH
- Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses
- (2011) M. B. Davis et al. CLINICAL CANCER RESEARCH
- Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4
- (2011) J D Dias et al. GENE THERAPY
- Treatment of Locally Recurrent Mucosal Melanoma With Topical Imiquimod
- (2011) Elizabeth C. Smyth et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma
- (2011) Stephen J. Schuster et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus
- (2011) Vincenzo Cerullo et al. MOLECULAR THERAPY
- A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma
- (2011) Tae-Ho Hwang et al. MOLECULAR THERAPY
- The Oncolytic Poxvirus JX-594 Selectively Replicates in and Destroys Cancer Cells Driven by Genetic Pathways Commonly Activated in Cancers
- (2011) Kelley A Parato et al. MOLECULAR THERAPY
- Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans
- (2011) Caroline J. Breitbach et al. NATURE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- High response rate after intratumoral treatment with interleukin-2
- (2010) Benjamin Weide et al. CANCER
- Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-α and IFN-γ dependent manners
- (2010) Xinmei Zhu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
- (2010) K. J. Harrington et al. CLINICAL CANCER RESEARCH
- In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
- (2010) Joshua D. Brody et al. JOURNAL OF CLINICAL ONCOLOGY
- Regression of Established AB1 Murine Mesothelioma Induced by Peritumoral Injections of CpG Oligodeoxynucleotide Either Alone or in Combination with Poly(I:C) and CD40 Ligand Plasmid DNA
- (2010) Geoffrey W. Stone et al. Journal of Thoracic Oncology
- HSF1 overexpression enhances oncolytic effect of replicative adenovirus
- (2010) Cheng Wang et al. Journal of Translational Medicine
- Potentiating Cancer Immunotherapy Using an Oncolytic Virus
- (2010) Byram W Bridle et al. MOLECULAR THERAPY
- A multi-institution phase II study of poly-ICLC and radiotherapy with concurrent and adjuvant temozolomide in adults with newly diagnosed glioblastoma
- (2010) M. R. Rosenfeld et al. NEURO-ONCOLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
- (2009) Claire Banissi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus
- (2009) Byram W Bridle et al. MOLECULAR THERAPY
- Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma
- (2009) Geoffrey W. Stone et al. PLoS One
- Immunotransplantation preferentially expands T-effector cells over T-regulatory cells and cures large lymphoma tumors
- (2008) J. D. Brody et al. BLOOD
- Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
- (2008) M. Di Nicola et al. BLOOD
- T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
- (2008) R. Houot et al. BLOOD
- Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity
- (2008) Andrew D. Simmons et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- LPS/TLR4 signal transduction pathway
- (2008) Yong-Chen Lu et al. CYTOKINE
- A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients
- (2008) J-L Li et al. GENE THERAPY
- Arming parvoviruses with CpG motifs to improve their oncosuppressive capacity
- (2008) Zahari Raykov et al. INTERNATIONAL JOURNAL OF CANCER
- An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial
- (2008) Christopher Wood et al. LANCET
- Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
- (2008) Byeong-Ho Park et al. LANCET ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started